Patient-Reported Burden of Illness in a Prevalent COPD Population Treated with Long-Acting Muscarinic Antagonist Monotherapy: A Claims-Linked Patient Survey Study

Patient-Reported Burden of Illness in a Prevalent COPD Population Treated with Long-Acting Muscarinic Antagonist Monotherapy: A Claims-Linked Patient Survey Study

Abstract Introduction Symptom burden in inadequately controlled chronic obstructive pulmonary disease (COPD) considerably impacts quality of life, healthcare resource utilization (HCRU) and associated costs. This claims-linked cross-sectional survey study assessed symptom burden and HCRU among a pre...

Full description

Bibliographic Details
Main Authors: Beth Hahn, Richard H. Stanford, Alyssa Goolsby Hunter, Breanna Essoi, John White, Riju Ray
Format: Article
Language:English
Published: Adis, Springer Healthcare 2019-04-01
Series:Pulmonary Therapy
Subjects:
Bronchodilator agents
COPD
Health surveys
Patient-reported outcomes
Online Access:http://link.springer.com/article/10.1007/s41030-019-0091-0

Internet

http://link.springer.com/article/10.1007/s41030-019-0091-0

Similar Items